Stocksigma LogoStocksigma Logo

Anlon Healthcare Discloses Revised Preferential Issue Pricing and Allottee Details

Following shareholder approval on 5th Sep'26 for acquiring 44.94% of Apiqo Organics and 47.41% of Bizotic Lifescience via a share swap, Anlon Healthcare

Anlon Healthcare Discloses Revised Preferential Issue Pricing and Allottee Details

Anlon Healthcare Ltd 路 Others (Uncategorized) 路 21 Sept 2026, 8:32 pm

Anlon Healthcare Discloses Revised Preferential Issue Pricing and Allottee Details Following shareholder approval on 5th Sep'26 for acquiring 44.94% of Apiqo Organics and 47.41% of Bizotic Lifescience via a share swap, Anlon Healthcare issued revised preferential issue disclosures responding to exchange queries. Under SEBI ICDR norms, the preferential issue floor price is fixed at Rs.17.85 per share, matching the 90-day NSE VWAP and independent fair valuation dated 1st Sep'26. The company also disclosed ultimate beneficial ownership details across 26 proposed allottees and uploaded the compliance certificate from practicing company secretaries.

Original exchange filing (PDF)

More announcements from Anlon Healthcare Ltd

All Anlon Healthcare Ltd announcements